Clominorex
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
|
|
CAS Number | 3876-10-6 ![]() |
PubChem (CID) | 19752 |
ChemSpider | 18605 ![]() |
UNII | O1R2462WA0 ![]() |
KEGG | D03552 ![]() |
ChEMBL | CHEMBL2104179 |
Chemical and physical data | |
Formula | C9H9ClN2O |
Molar mass | 196.63 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
|
|
|
|
(verify) |
Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also[edit]
References[edit]
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (September 2009) (Learn how and when to remove this template message) |
- ^ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |